February 10, 2021– While hospitals across the country have been struggling to stay afloat and serve the health needs of a nation during a historic pandemic, one of the largest drug companies in the U.S. has been boosting its already huge profits by … [Read More...]
340B Hospitals Are Key to the Pursuit of Health Equity
Print ArticleFebruary 8, 2021– A global pandemic, an economic recession, and social strife in communities across the nation have cast a bright light on the deep racial and ethnic inequities in the U.S., starting a national dialogue that aspires to put us on a path toward real change. President Biden and his administration have made […]
Senate Report Blasts Insulin Makers for High Prices
Print ArticleJanuary 21, 2021– A new, bipartisan report from a key congressional committee is sharply critical of the three major drug manufacturers that sell insulin in the U.S. The companies – Eli Lilly, Novo Nordisk, and Sanofi – already have been all over the news recently for their pricing behavior. They also are the ringleaders […]
FOLLOW | SHARE | LIKE
